Kashif Sadiq

Digital

Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.

News

A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.